Income Statement Venus Concept Inc.
Stocks
VERO
US92332W3034
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3105 USD | +2.56% |
|
-.--% | -79.02% |
| 05-14 | Venus Concept Inc. Announces Senior Management Changes | CI |
| 04-09 | Venus Concept Inc. announced that it has received $1.5 million in funding | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
Revenues | 78.01M | 106M | 99.5M | 76.35M | 64.83M | ||||
Total Revenues | 78.01M | 106M | 99.5M | 76.35M | 64.83M | ||||
Cost of Goods Sold, Total | 26.62M | 31.53M | 33.53M | 24.19M | 20.53M | ||||
Gross Profit | 51.39M | 74.09M | 65.97M | 52.17M | 44.31M | ||||
Selling General & Admin Expenses, Total | 74.11M | 83.38M | 89.89M | 72.28M | 64.8M | ||||
Provision for Bad Debts | - | - | - | - | - | ||||
R&D Expenses | 7.75M | 8.26M | 10.95M | 8.2M | 6.69M | ||||
Other Operating Expenses, Total | 81.87M | 91.64M | 101M | 80.48M | 71.49M | ||||
Operating Income | -30.48M | -17.54M | -34.88M | -28.31M | -27.18M | ||||
Interest Expense, Total | -8.34M | -4.96M | -4.56M | -6.89M | -7.66M | ||||
Net Interest Expenses | -8.34M | -4.96M | -4.56M | -6.89M | -7.66M | ||||
Currency Exchange Gains (Loss) | 68K | -2.56M | -3.39M | 295K | -2.14M | ||||
Other Non Operating Income (Expenses) | - | - | - | - | 771K | ||||
EBT, Excl. Unusual Items | -38.75M | -25.06M | -42.82M | -34.91M | -36.2M | ||||
Merger & Related Restructuring Charges | - | - | - | - | - | ||||
Impairment of Goodwill | -27.45M | - | - | - | - | ||||
Gain (Loss) On Sale Of Assets | -2.53M | -567K | -1.48M | -174K | -23K | ||||
Other Unusual Items | -12.91M | 2.78M | - | -2.04M | -11.36M | ||||
EBT, Incl. Unusual Items | -81.64M | -22.85M | -44.31M | -37.12M | -47.58M | ||||
Income Tax Expense | 1.18M | -707K | -722K | -71K | -611K | ||||
Earnings From Continuing Operations | -82.82M | -22.14M | -43.58M | -37.05M | -46.97M | ||||
Net Income to Company | -82.82M | -22.14M | -43.58M | -37.05M | -46.97M | ||||
Minority Interest | 1.11M | -872K | -116K | -200K | -25K | ||||
Net Income - (IS) | -81.71M | -23.01M | -43.7M | -37.25M | -47M | ||||
Preferred Dividend and Other Adjustments | 3.56M | - | - | - | - | ||||
Net Income to Common Incl Extra Items | -85.27M | -23.01M | -43.7M | -37.25M | -47M | ||||
Net Income to Common Excl. Extra Items | -85.27M | -23.01M | -43.7M | -37.25M | -47M | ||||
Per Share Items | |||||||||
Net EPS - Basic | -384.14 | -69.72 | -109.32 | -75.29 | -71.21 | ||||
Basic EPS - Continuing Operations | -384.14 | -69.72 | -109.32 | -75.29 | -71.21 | ||||
Basic Weighted Average Shares Outstanding | 222K | 330K | 400K | 495K | 660K | ||||
Net EPS - Diluted | -384.45 | -69.72 | -109.32 | -75.29 | -71.21 | ||||
Diluted EPS - Continuing Operations | -384.45 | -69.72 | -109.32 | -75.29 | -71.21 | ||||
Diluted Weighted Average Shares Outstanding | 222K | 330K | 400K | 495K | 660K | ||||
Normalized Basic EPS | -104.1 | -50.08 | -67.24 | -44.5 | -34.32 | ||||
Normalized Diluted EPS | -104.1 | -50.08 | -67.24 | -44.5 | -34.32 | ||||
Supplemental Items | |||||||||
EBITDA | -25.67M | -12.69M | -30.41M | -24.19M | -23.3M | ||||
EBITA | -27M | -14.07M | -31.4M | -24.84M | -23.71M | ||||
EBIT | -30.48M | -17.54M | -34.88M | -28.31M | -27.18M | ||||
EBITDAR | -23.71M | -10.5M | -28.2M | -22.26M | -21.84M | ||||
Total Revenues (As Reported) | 78.01M | 106M | 99.5M | 76.35M | 64.83M | ||||
Effective Tax Rate - (Ratio) | -1.45 | 3.09 | 1.63 | 0.19 | 1.28 | ||||
Current Foreign Taxes | - | - | - | -2K | -168K | ||||
Total Current Taxes | 1.62M | -542K | -13K | -2K | -168K | ||||
Deferred Foreign Taxes | - | - | - | -69K | -443K | ||||
Total Deferred Taxes | -438K | -165K | -709K | -69K | -443K | ||||
Normalized Net Income | -23.11M | -16.53M | -26.88M | -22.02M | -22.65M | ||||
Interest Capitalized | - | - | - | - | - | ||||
Interest on Long-Term Debt | - | 1.24M | 4.56M | 6.89M | 7.66M | ||||
Supplemental Operating Expense Items | |||||||||
Advertising Expense | 1.09M | 1.82M | 1.78M | 1.12M | 1.22M | ||||
Selling and Marketing Expenses | 26.2M | 37.44M | 40.28M | 31.23M | 28.33M | ||||
General and Administrative Expenses | 47.91M | 45.94M | 49.62M | 41.05M | 36.47M | ||||
Research And Development Expense From Footnotes | 7.75M | 8.26M | 10.95M | 8.2M | 6.69M | ||||
Net Rental Expense, Total | 1.96M | 2.19M | 2.21M | 1.93M | 1.46M | ||||
Imputed Operating Lease Interest Expense | 1.74M | 1.1M | 998K | 1.3M | 1.45M | ||||
Imputed Operating Lease Depreciation | 220K | 1.09M | 1.21M | 629K | 2.71K | ||||
Stock-Based Comp., COGS (Total) | 25K | 31K | 73K | 47K | 36K | ||||
Stock-Based Comp., R&D Exp. (Total) | 90K | 105K | 260K | 144K | 99K | ||||
Stock-Based Comp., S&M Exp. (Total) | 872K | 848K | 576K | 343K | 246K | ||||
Stock-Based Comp., G&A Exp. (Total) | 1.15M | 1.08M | 1.2M | 1.04M | 662K | ||||
Stock-Based Comp., Other (Total) | - | - | - | - | - | ||||
Total Stock-Based Compensation | 2.14M | 2.07M | 2.1M | 1.57M | 1.04M |
- Stock Market
- Stocks
- VERO Stock
- Financials Venus Concept Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















